Abstract
The generation of new myelin-forming oligodendrocytes in the adult central nervous system is critical for cognitive function and regeneration following injury. Oligodendrogenesis varies between gray and white matter regions, suggesting that local cues drive regional differences in myelination and the capacity for regeneration. However, the layer- and region-specific regulation of oligodendrocyte populations is unclear due to the inability to monitor deep brain structures in vivo. Here we harnessed the superior imaging depth of three-photon microscopy to permit long-term, longitudinal in vivo three-photon imaging of the entire cortical column and subcortical white matter in adult mice. We find that cortical oligodendrocyte populations expand at a higher rate in the adult brain than those of the white matter. Following demyelination, oligodendrocyte replacement is enhanced in the white matter, while the deep cortical layers show deficits in regenerative oligodendrogenesis and the restoration of transcriptional heterogeneity. Together, our findings demonstrate that regional microenvironments regulate oligodendrocyte population dynamics and heterogeneity in the healthy and diseased brain.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
All data that support the findings, tools, and reagents will be shared on an unrestricted basis; requests should be directed to the corresponding author.
Code availability
Code for analysis associated with the manuscript is available at https://github.com/EthanHughesLab/; RNAScope analysis scripts are available at https://github.com/sbudoff/. The code to measure the brightest n% of pixels through a z-stack or time series was modified from macro scripts available via the NYU Imaging Core website https://microscopynotes.com/imagej/. The AO image optimization and plotting scripts are available at the Intelligent Imaging Innovations (3i) Github at https://github.com/3i-microscopes/Adaptive-Optics.
References
Flechsig Of Leipsic, P. Developmental (myelogenetic) localisation of the cerebral cortex in the human subject. Lancet 158, 1027–1030 (1901).
Spitzer, S. O. et al. Oligodendrocyte progenitor cells become regionally diverse and heterogeneous with age. Neuron 101, 459–471.e5 (2019).
Dimou, L., Simon, C., Kirchhoff, F., Takebayashi, H. & Götz, M. Progeny of Olig2-expressing progenitors in the gray and white matter of the adult mouse cerebral cortex. J. Neurosci. 28, 10434–10442 (2008).
Kang, S. H., Fukaya, M., Yang, J. K., Rothstein, J. D. & Bergles, D. E. NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration. Neuron 68, 668–681 (2010).
Viganò, F., Möbius, W., Götz, M. & Dimou, L. Transplantation reveals regional differences in oligodendrocyte differentiation in the adult brain. Nat. Neurosci. 16, 1370–1372 (2013).
Marques, S. et al. Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system. Science 352, 1326–1329 (2016).
Floriddia, E. M. et al. Distinct oligodendrocyte populations have spatial preference and different responses to spinal cord injury. Nat. Commun. 11, 5860 (2020).
Hilscher, M. M. et al. Spatial and temporal heterogeneity in the lineage progression of fine oligodendrocyte subtypes. BMC Biol. 20, 122 (2022).
Pandey, S. et al. Disease-associated oligodendrocyte responses across neurodegenerative diseases. Cell Rep. 40, 111189 (2022).
Falcão, A. M. et al. Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis. Nat. Med. 24, 1837–1844 (2018).
Jäkel, S. et al. Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature 566, 543–547 (2019).
Snaidero, N. et al. Myelin replacement triggered by single-cell demyelination in mouse cortex. Nat. Commun. 11, 4901 (2020).
Smith, K. J., Blakemore, W. F. & Mcdonald, W. I. Central remyelination restores secure conduction. Nature 280, 395–396 (1979).
Bacmeister, C. M. et al. Motor learning promotes remyelination via new and surviving oligodendrocytes. Nat. Neurosci. 23, 819–831 (2020).
Bø, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D. & Mørk, S. J. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J. Neuropathol. Exp. Neurol. 62, 723–732 (2003).
Kutzelnigg, A. et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128, 2705–2712 (2005).
Peterson, J. W., Bö, L., Mörk, S., Chang, A. & Trapp, B. D. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol. 50, 389–400 (2001).
Helmchen, F. & Denk, W. Deep tissue two-photon microscopy. Nat. Methods 2, 932–940 (2005).
Orthmann-Murphy, J. et al. Remyelination alters the pattern of myelin in the cerebral cortex. eLife 9, e56621 (2020).
Call, C. L. & Bergles, D. E. Cortical neurons exhibit diverse myelination patterns that scale between mouse brain regions and regenerate after demyelination. Nat. Commun. 12, 4767 (2021).
Horton, N. G. et al. In vivo three-photon microscopy of subcortical structures within an intact mouse brain. Nat. Photon 7, 205–209 (2013).
Streich, L. et al. High-resolution structural and functional deep brain imaging using adaptive optics three-photon microscopy. Nat. Methods 18, 1253–1258 (2021).
Ouzounov, D. G. et al. In vivo three-photon imaging of activity of GCaMP6-labeled neurons deep in intact mouse brain. Nat. Methods 14, 388–390 (2017).
Wang, T., Wang, T. & Xu, C. Three-photon neuronal imaging in deep mouse brain. Optica 7, 947–960 (2020).
Hughes, E. G., Orthmann-Murphy, J. L., Langseth, A. J. & Bergles, D. E. Myelin remodeling through experience-dependent oligodendrogenesis in the adult somatosensory cortex. Nat. Neurosci. 21, 696–706 (2018).
Squier, J., Muller, M., Brakenhoff, G. & Wilson, K. R. Third harmonic generation microscopy. Opt. Express 3, 315–324 (1998).
Débarre, D. et al. Imaging lipid bodies in cells and tissues using third-harmonic generation microscopy. Nat. Methods 3, 47–53 (2006).
Yildirim, M., Sugihara, H., So, P. T. C. & Sur, M. Functional imaging of visual cortical layers and subplate in awake mice with optimized three-photon microscopy. Nat. Commun. 10, 177 (2019).
Schain, A. J., Hill, R. A. & Grutzendler, J. Label-free in vivo imaging of myelinated axons in health and disease with spectral confocal reflectance microscopy. Nat. Med. 20, 443–449 (2014).
Paxinos, G. & Franklin, K. B. J. Paxinos and Franklin’s the Mouse Brain in Stereotaxic Coordinates (Academic Press, 2019).
Chapman, T. W., Olveda, G. E., Bame, X., Pereira, E. & Hill, R. A. Oligodendrocyte death initiates synchronous remyelination to restore cortical myelin patterns in mice. Nat. Neurosci. 26, 555–569 (2023).
Yildirim, M. et al. Quantitative third-harmonic generation imaging of mouse visual cortex areas reveals correlations between functional maps and structural substrates. Biomed. Opt. Express 11, 5650–5673 (2020).
Podgorski, K. & Ranganathan, G. Brain heating induced by near-infrared lasers during multiphoton microscopy. J. Neurophysiol. 116, 1012–1023 (2016).
Wang, T. et al. Quantitative analysis of 1300 nm three-photon calcium imaging in the mouse brain. eLife 9, e53205 (2020).
Nunomura, A. et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer’s disease. J. Neurosci. 19, 1959–1964 (1999).
Arganda-Carreras, I. et al. Trainable Weka segmentation: a machine learning tool for microscopy pixel classification. Bioinformatics 33, 2424–2426 (2017).
Schager, B. & Brown, C. E. Susceptibility to capillary plugging can predict brain region specific vessel loss with aging. J. Cereb. Blood Flow. Metab. 40, 2475–2490 (2020).
Tripathi, R. B. et al. Remarkable stability of myelinating oligodendrocytes in mice. Cell Rep. 21, 316–323 (2017).
Zhu, X. et al. Age-dependent fate and lineage restriction of single NG2 cells. Development 138, 745–753 (2011).
Dawson, M. R. L., Polito, A., Levine, J. M. & Reynolds, R. NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol. Cell. Neurosci. 24, 476–488 (2003).
Rosenberg, S. S., Kelland, E. E., Tokar, E., De la Torre, A. R. & Chan, J. R. The geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation. Proc. Natl Acad. Sci. USA 105, 14662–14667 (2008).
Hill, R. A., Li, A. M. & Grutzendler, J. Lifelong cortical myelin plasticity and age-related degeneration in the live mammalian brain. Nat. Neurosci. 21, 683–695 (2018).
Skripuletz, T. et al. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am. J. Pathol. 172, 1053–1061 (2008).
Gudi, V. et al. Regional differences between grey and white matter in cuprizone induced demyelination. Brain Res. 1283, 127–138 (2009).
Wergeland, S., Torkildsen, Ø., Myhr, K.-M., Mørk, S. J. & Bø, L. The cuprizone model: regional heterogeneity of pathology. APMIS 120, 648–657 (2012).
Baxi, E. G. et al. Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelination. Glia 65, 2087–2098 (2017).
Tjørve, K. M. C. & Tjørve, E. The use of Gompertz models in growth analyses, and new Gompertz-model approach: an addition to the unified-Richards family. PLoS ONE 12, e0178691 (2017).
Wang, F. et al. Myelin degeneration and diminished myelin renewal contribute to age-related deficits in memory. Nat. Neurosci. 23, 481–486 (2020).
Thornton, M. A. & Hughes, E. G. Neuron–oligodendroglia interactions: activity-dependent regulation of cellular signaling. Neurosci. Lett. 727, 134916 (2020).
Young, K. M. et al. Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling. Neuron 77, 873–885 (2013).
Hughes, E. G., Kang, S. H., Fukaya, M. & Bergles, D. E. Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain. Nat. Neurosci. 16, 668–676 (2013).
Hontani, Y., Xia, F. & Xu, C. Multicolor three-photon fluorescence imaging with single-wavelength excitation deep in mouse brain. Sci. Adv. 7, eabf3531 (2021).
Thornton, M. A. et al. Characterization of red fluorescent reporters for dual-color in vivo three-photon microscopy. Neurophotonics 9, 031912 (2022).
Albert, M., Antel, J., Brück, W. & Stadelmann, C. Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol. 17, 129–138 (2007).
Remington, L. T., Babcock, A. A., Zehntner, S. P. & Owens, T. Microglial recruitment, activation, and proliferation in response to primary demyelination. Am. J. Pathol. 170, 1713–1724 (2007).
Franklin, R. J. M. & ffrench-Constant, C. Regenerating CNS myelin—from mechanisms to experimental medicines. Nat. Rev. Neurosci. 18, 753–769 (2017).
Sherafat, A., Pfeiffer, F., Reiss, A. M., Wood, W. M. & Nishiyama, A. Microglial neuropilin-1 promotes oligodendrocyte expansion during development and remyelination by trans-activating platelet-derived growth factor receptor. Nat. Commun. 12, 2265 (2021).
Samanta, J. et al. Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination. Nature 526, 448–452 (2015).
Armingol, E., Officer, A., Harismendy, O. & Lewis, N. E. Deciphering cell–cell interactions and communication from gene expression. Nat. Rev. Genet. 22, 71–88 (2021).
Chang, A. et al. Cortical remyelination: a new target for repair therapies in multiple sclerosis. Ann. Neurol. 72, 918–926 (2012).
Strijbis, E. M. M., Kooi, E.-J., van der Valk, P. & Geurts, J. J. G. Cortical remyelination is heterogeneous in multiple sclerosis. J. Neuropathol. Exp. Neurol. 76, 390–401 (2017).
Geurts, J. J. G. & Barkhof, F. Grey matter pathology in multiple sclerosis. Lancet Neurol. 7, 841–851 (2008).
Lentferink, D. H., Jongsma, J. M., Werkman, I. & Baron, W. Grey matter OPCs are less mature and less sensitive to IFNγ than white matter OPCs: consequences for remyelination. Sci. Rep. 8, 2113 (2018).
Kirby, L. et al. Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination. Nat. Commun. 10, 3887 (2019).
Kotter, M. R., Li, W.-W., Zhao, C. & Franklin, R. J. M. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J. Neurosci. 26, 328–332 (2006).
Harris, K. D. & Shepherd, G. M. G. The neocortical circuit: themes and variations. Nat. Neurosci. 18, 170–181 (2015).
Madsen, M. A. J. et al. Linking lesions in sensorimotor cortex to contralateral hand function in multiple sclerosis: a 7 T MRI study. Brain https://doi.org/10.1093/brain/awac203. (2022).
Battefeld, A., Klooster, J. & Kole, M. H. P. Myelinating satellite oligodendrocytes are integrated in a glial syncytium constraining neuronal high-frequency activity. Nat. Commun. 7, 11298 (2016).
Dubey, M. et al. Myelination synchronizes cortical oscillations by consolidating parvalbumin-mediated phasic inhibition. eLife 11, e73827 (2022).
Schirmer, L. et al. Neuronal vulnerability and multilineage diversity in multiple sclerosis. Nature 573, 75–82 (2019).
Rodríguez, C. et al. An adaptive optics module for deep tissue multiphoton imaging in vivo. Nat. Methods 18, 1259–1264 (2021).
Ren, C. & Komiyama, T. Wide-field calcium imaging of cortex-wide activity in awake, head-fixed mice. STAR Protoc. 2, 100973 (2021).
Squier, J. A. & Müller, M. Third-harmonic generation imaging of laser-induced breakdown in glass. Appl. Opt. 38, 5789–5794 (1999).
Sinefeld, D. et al. Three-photon adaptive optics for mouse brain imaging. Front. Neurosci. 16, 880859 (2022).
Champelovier, D. et al. Image-based adaptive optics for in vivo imaging in the hippocampus. Sci. Rep. 7, 42924 (2017).
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
Lein, E. S. et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445, 168–176 (2007).
Thevenaz, P., Ruttimann, U. E. & Unser, M. A pyramid approach to subpixel registration based on intensity. IEEE Trans. Image Process. 7, 27–41 (1998).
Rezakhaniha, R. et al. Experimental investigation of collagen waviness and orientation in the arterial adventitia using confocal laser scanning microscopy. Biomech. Model. Mechanobiol. 11, 461–473 (2012).
Püspöki, Z., Storath, M., Sage, D. & Unser, M. Transforms and operators for directional bioimage analysis: a survey. Adv. Anat. Embryol. Cell Biol. 219, 69–93 (2016).
Chehrehasa, F., Meedeniya, A. C. B., Dwyer, P., Abrahamsen, G. & Mackay-Sim, A. EdU, a new thymidine analogue for labelling proliferating cells in the nervous system. J. Neurosci. Methods 177, 122–130 (2009).
Zeng, C. et al. Evaluation of 5-ethynyl-2′-deoxyuridine staining as a sensitive and reliable method for studying cell proliferation in the adult nervous system. Brain Res. 1319, 21–32 (2010).
Cieślar-Pobuda, A. & Łos, M. J. Prospects and limitations of ‘click-chemistry’-based DNA labeling technique employing 5-ethynyl-2′deoxyuridine (EdU). Cytom. Part A 83, 977–978 (2013).
Kohlmeier, F., Maya-Mendoza, A. & Jackson, D. A. EdU induces DNA damage response and cell death in mESC in culture. Chromosome Res. 21, 87–100 (2013).
Peng, T. et al. A BaSiC tool for background and shading correction of optical microscopy images. Nat. Commun. 8, 14836 (2017).
Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).
OligoRNAscopeTools. GitHub https://github.com/sbudoff/OligoRNAscopeTools (2023).
Maino, J. L. & Kearney, M. R. Testing mechanistic models of growth in insects. Proc. R. Soc. B 282, 20151973 (2015).
Laird, A. K. Dynamics of tumour growth. Br. J. Cancer 18, 490–502 (1964).
Benzekry, S. et al. Classical mathematical models for description and prediction of experimental tumor growth. PLoS Comput. Biol. 10, e1003800 (2014).
Acknowledgements
We thank M. Hall for machining expertise, A. Scallon and the University of Colorado Anschutz Optogenetics and Neural Engineering Core (P30NS048154) for 3D printing and stage design, past and current members of the Hughes Lab and the University of Colorado Anschutz Myelin Research Group for discussions, J. Siegenthaler and S. Bonney (Andy Shih Lab) for helpful discussions on the vascular and pericyte analyses. M. Cammer for assistance with the histogram measurement ImageJ macros (New York University Langone Health Imaging Core). D. Stitch and the University of Colorado Anschutz Medical Campus Advanced Light Microscopy Core Facility of the NeuroTechnology Center that is supported in part by Rocky Mountain Neurological Disorders Core (P30NS048154) and by Diabetes Research Center (P30DK116073) for assistance with RNAScope imaging. Funding was provided by the National Institute of Neurological Disorders and Stroke (F31NS120540) to M.A.T. Funding was provided by the University of Colorado Department of Cell and Developmental Biology Pilot grant, the Whitehall Foundation and the National Multiple Sclerosis Society (RG-1701–26733) and National Institute of Neurological Disorders and Stroke (NS115975, NS125230 and NS132859) to E.G.H. Funding was provided by the National Institute of Neurological Disorders and Stroke (R01 NS118188 and UF1 NS116241) and the National Science Foundation (BCS-1926676) to E.A.G. and D.R. Funding was provided by the National Institutes of Health National Eye Institute (R01 EY030841) to A.P.-P.
Author information
Authors and Affiliations
Contributions
E.G.H. and M.A.T. conceived the project. M.A.T. designed and performed experiments, analyzed data and generated all figures. G.L.F. and E.A.G. built the three-photon microscope. M.E.S., S.A.B. and M.A.T. performed the RNA ISH labeling and imaging experiments. M.E.S. and S.A.B. analyzed the RNA ISH data. M.E.S. contributed images and data to Figs. 4–8 and Extended Data Figs. 7 and 9. S.A.B. contributed images and data to Figs. 4–7 and Extended Data Figs. 7 and 9 and wrote the R code to analyze the QuPath output datasets (see ‘Code availability’). A.N.R. performed experiments and analyzed data for Figs. 2 and 3 and Extended Data Figs. 4 and 5. B.O., O.T. and K.K. developed the software and helped with three-photon microscope setup and expertise. E.A.G., D.R. and E.G.H. supervised the three-photon microscope development and application. E.A.G., D.R., A.P.-P. and E.G.H. secured funding and E.G.H. supervised the project. M.A.T. and E.G.H. wrote the paper with input from other authors.
Corresponding author
Ethics declarations
Competing interests
K.K. is a co-founder and part-owner of 3i. The other authors declare no competing financial interests.
Peer review
Peer review information
Nature Neuroscience thanks Erin Gibson and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Custom three-photon light path and modifications for longitudinal in vivo imaging.
3P excitation source and light path, including motorized half-wave plate for power modulation (λ/2), Glan-Thompson polarizer (GT), dual prism compressor, beam expanding telescope, ALPAO deformable mirror, beam reduction lens relay, galvo-galvo scan mirrors, scan lens, tube lens, dichroic mirror (FF-488-di02, cut at 488 nm), and moveable objective microscope system with collection filters for third harmonic generation signal (430/25 nm, PMT1) and EGFP emission (520/70 nm, PMT2).
Extended Data Fig. 2 Mobp-EGFP and THG labeling of mature oligodendrocytes and myelin in the cortex and subcortical white matter.
a) Confocal image of a tissue section from the deep posterior parietal cortex stained for transgenic Mobp-EGFP and ASPA. Arrowheads show large, putative newly-generated oligodendrocytes that are MOBP-EGFP-positive and ASPA-negative. b) Confocal image of ASPA/Mobp-EGFP immunofluorescence in the subcortical white matter beneath the posterior parietal cortex (dotted white lines). Arrowheads show Mobp-EGFP-positive and ASPA-negative white matter oligodendrocytes of varying sizes and brightness. c) 99.5% (cortex) and 99.6% (white matter) of ASPA-positive cells express MOBP-EGFP. n = 4 mice, 2 sections per mouse. d) 95.6% (cortex) vs. 86.5% (white matter) of Mobp-EGFP-positive oligodendrocytes were also positive for ASPA (Unpaired, two-tailed Student’s t-test for equal variance, p = 0.016). n = 4 mice, 2 sections per mouse. e) 9 μm z-projection of layer 1 in the posterior parietal cortex showing Mobp-EGFP labeling of myelin sheaths (green) and THG-labeling of myelin sheaths and blood vessels (magenta). f) Zoom image of an isolated EGFP/THG-labeled myelin sheath from the white box in (e) excited with 1300 nm three-photon excitation. g) Isolated Mobp-EGFP sheath from layer 1 of a separate mouse visualized with 920 nm two-photon excitation combined with Spectral Confocal Reflectance (SCoRe) microscopy. Note the decreased THG/SCoRe labeling at putative nodes of Ranvier in (f) and (g) (arrowheads). h) 9 μm z-projection of a single mature oligodendrocyte in layer 1 from a third mouse showing EGFP-labeled processes connected to multiple THG-labeled sheaths. i) 5-pixel line intensity plot from the white line drawn in (d) showing relative fluorescence intensity of EGFP- and THG-labeled myelin sheaths and a THG-labeled blood vessel (arrowhead). All images pixel size = 0.36 μm. *p < 0.05, box plots represent the median, interquartile ranges and minimum/maximum values.
Extended Data Fig. 3 Adaptive optics improves SBR and axial resolution in the subcortical white matter.
a) System adaptive optics (AO) correction with a two-dimensional 1.0 µm red polychromatic microsphere sample. Lateral (top) and axial (bottom) projections show a slight enhancement in peak signal after AO correction for system aberrations (8% increase, lateral; 9% increase, axial). The bead sample was diluted 1:10000, coverslipped with Prolong Gold, and the average power at the sample was <0.3 mW. System resolution = 0.88 µm (lateral) and 2.55 µm (axial) as calculated by the full width at half maximum of the gaussian fit after system AO correction. b) Deformable mirror (DM) amplitude plot showing the optimized stroke amplitudes (units = µm RMS) for each Zernike Mode in the system AO correction. c) In vivo, indirect, modal adaptive optics (AO) corrections were made at 775–825 µm depth (just above the white matter) by optimizing on the mean intensity of the third harmonic generation channel. The in vivo AO correction revealed cross sections through myelinated axons just dorsal to the corpus callosum (white dotted selection, top, 800 µm) and increased the mean intensity of EGFP-positive oligodendrocytes in the white matter ventral to the plane of the AO correction (bottom, 835 µm). Example images are single-slice images at the depth of the AO correction, 0.14 µm / pixel. d) Deformable mirror (DM) amplitude plot showing the optimized stroke amplitudes (units = µm RMS) for each Zernike Mode in the in vivo AO correction shown in (c). e) (Left) XY (top) and XZ (bottom) projections for a single EGFP-positive OL cell body from the example image shown in (c). (Right) Lateral and axial Gaussian fits of OL cell bodies from the field of view in (c). f) The peak intensity of the EGFP-oligodendrocyte signal was significantly enhanced by the AO correction (Paired, two-tailed Student’s t-test, p = 0.0002, n = 2 mice, 11 cells). g) The axial resolution of EGFP-oligodendrocyte cell bodies was significantly enhanced by the AO correction (Paired, two-tailed Student’s t-test, p = 0.014, n = 2 mice, 11 cells). h) AO correction enhances the peak intensity of OL processes by 202% (n = 2 mice, 4 processes). i) Average power vs. depth plot shows the average power at the sample through the depth of the white matter after AO correction (black, left), and the theoretical power curve (gray, right) necessary to maintain the same signal to background ratio without AO. Data are represented as individual points and mean ± SEM. Curves in a, e, and h represent the mean of the gaussian fits for each analyzed region (cell bodies in a, e, cell processes in h) with 95% confidence intervals. The intensity was integrated over a line plotted through the center of the cell structure (10 µm wide, cell bodies, 1 µm wide, processes). Zernike modes in (b), (d) = Spherical (12), Horizontal Trefoil (9), Horizontal Coma (8), Vertical Coma (7), Oblique Trefoil (6), Astigmatism (5), Oblique Astigmatism (3). For detailed statistics, see Supplementary Table 3.
Extended Data Fig. 4 Mechanical, scanning, and optical modifications to increase 3P signal and decrease average power.
a) The third harmonic generation (THG) signal at the surface of the cranial window was used to align the preparation orthogonally to the excitation light. b) Scanning modifications to increase SBR and decrease average power to mitigate risk of tissue damage. Frame averaging was advantageous compared to increasing the pixel dwell time to reduce risk of nonlinear damage. Z-stack acquisition was paused periodically to allow for heat dissipation (1 min. pause per 3 min. scanning). Laser pulses were blanked on the galvanometer overscan to reduce the average power applied to the preparation at each z-plane. c) Imaged-based AO correction increased SBR at depth (left) and modulating the spherical aberration correction linearly with depth improved SBR throughout the imaging volume (right). For longitudinal imaging, the AO correction was made before acquiring each time point at the same z-plane just above the scattering white matter (750–850 µm depth).
Extended Data Fig. 5 Calculation of mouse-specific effective attenuation lengths in the posterior parietal cortex.
a) The mean intensity of the top 1% of the brightest pixels (experimental 3P signal) plotted with depth beneath the brain surface for an example mouse. b) Data from the mouse shown in (a) normalized to the cube of the pulse energy shows the decay of the 3P signal with depth in the mouse brain. c) Logarithm of the data in (b) shows a linear decrease with depth. The single mouse-specific effective attenuation length (EAL) can be calculated from the slope of the linear fit (gray = gray matter, blue = white matter). A steeper slope represents a shorter EAL due to increased scattering. d) Semilogarithmic plot showing gray matter and white matter EALs for n = 10 mice at the first time point of longitudinal imaging. Mean EAL (GM) = 249 ± 12.7 µm, Mean EAL (WM) = 169 ± 8.9 µm. e) Distributions of experimental mouse-specific EALs in the gray matter (gray) and white matter (blue). n = 10 mice. Linear fits (black line plots in c, d) were calculated separately by region. Box plots represent the median, interquartile ranges and minimum/maximum values.
Extended Data Fig. 6 Optimized longitudinal three-photon imaging does not increase glial, neuronal, or vascular reactivity.
a) Related to Fig. 3. Coronal brain section from the imaged (right) and contralateral (left) posterior parietal cortex (PPC) of a mouse that was perfused 24 hrs. following 10 weeks of chronic 3P imaging. b) Coronal brain section from the imaged (right) and contralateral (left) posterior parietal cortex (PPC) of a mouse that received supra-threshold excitation across the cortex and white matter to generate laser-induced positive control tissue (laser injury, right). c) High-resolution confocal images of the contralateral (left), longitudinal imaging field (middle) and laser-induced injury (right) regions in the deep cortical layers of the PPC, stained for transgenic Mobp-EGFP expression (mature oligodendrocytes), Iba-1 (microglia), GFAP (reactive astrocytes), 8-hydroxyguanosine (8-OHG, neuronal RNA oxidation), and CD13/Lectin-49 (pericytes, vasculature, respectively). All images were taken with identical power settings, processed with a 100-pixel rolling ball background subtraction and 0.7 pixel gaussian blur, and brightness/contrast correction was applied identically across channels. The bottom row shows an example of the trainable WEKA segmentation to measure pericytes (green) and vascular coverage (magenta, see Methods). Note the Lectin-positive microglia-like cells present in the laser injury vasculature image (white arrowheads). d) No difference in the density of Mobp-EGFP OLs between the contralateral and imaged regions in healthy mice. e) No difference in the density of Mobp-EGFP OLs between the contralateral and imaged regions in laser-induced injury tissue. f) The ratio of the EGFP mean intensity for the imaged:contralateral (contra.) hemispheres was ~1 for healthy mice and did not change significantly in the positive control tissue. g) No difference in the density of Iba-1 microglia (MG) between the contralateral and imaged regions in healthy mice. h) Density of Iba-1 MG is significantly increased on the ipsilateral side of laser-induced injury tissue (p = 0.016). i) The ratio of the imaged:contralateral Iba-1 mean intensity was ~1 for healthy mice and significantly increased in positive controls (p = 0.026). j) No difference in the density of GFAP-positive reactive astrocytes (rAstros) between the contralateral and imaged regions in healthy mice. k) Density of GFAP+ rAstros is significantly increased on the damaged side in laser-induced injury tissue (p = 0.017). l) The ratio of the imaged:contralateral (contra.) GFAP mean intensity was ~1 for healthy mice and was significantly increased in positive controls (p = 0.037). m) No difference in the density of 8-OHG-positive neurons after auto-thresholding (see Methods) between the contralateral and imaged regions in healthy mice. n) No difference in the density of 8-OHG-positive neurons between contralateral and imaged regions in laser-induced injury tissue. o) No difference in the imaged:contralateral ratio of 8-OHG mean intensities between healthy vs. laser-damaged mice. p) No difference in vessel coverage (% positive pixels) between the contralateral and imaged hemispheres of healthy multi-month longitudinal 3P imaging mice. q) Increase in vessel coverage (%) on the ipsilateral hemisphere of laser-induced injury positive control mice (p = 0.022). r) No difference in the density of pericytes between the contra. and ipsi. hemispheres of healthy long-term 3P mice. s) No difference in the density of pericytes between the contra. and ipsi. hemispheres of laser-induced injury mice. *p < 0.05, **p < 0.01, n.s., not significant; n = 5 mice (healthy longitudinal), 5 mice (laser-induced injury), 2 sections, 4 hemispheres per condition. Statistical comparisons in d, e, g-h, j-k, m-n, and p-s were made with paired, two-sided Student’s t-tests (parametric) or two-sided Wilcoxon signed-rank test (nonparametric). Statistical comparisons in f,i,l,o were made with unpaired two-sided Student’s t-tests for equal/unequal variances (parametric) or two-sided Wilcoxon rank sum test (nonparametric). Box plots represent the median, interquartile ranges and minimum/maximum values. For detailed statistics, see Supplementary Table 3.
Extended Data Fig. 7 Immunofluorescent and in situ hybridization techniques allow for probing OPC proliferation and oligodendrocyte subpopulations in the cortex and subcortical white matter.
a) Experimental timeline of tissue collection for EdU and RNAScope analyses in healthy and cuprizone mice. Healthy Mobp-EGFP mice were injected with 5 mg/kg of the thymidine analog EdU twice a day (10–12 hr. interval) for seven days starting at P70 and perfused the following day. Healthy Mobp-EGFP mice were perfused at P60 and P140 to assess aging-dependent changes in adult oligodendrocyte subpopulations. Mobp-EGFP mice that were fed 0.2% cuprizone for three weeks were perfused at 4 days post-cuprizone removal (peak demyelination, matched to in vivo imaging data; Fig. 4), and 7 weeks post-cuprizone removal (regeneration, matched to the final time point of in vivo imaging, see timeline; Fig. 4). b) EdU-positive proliferated OPCs in the posterior parietal cortex (top, GM) and subcortical white matter (bottom, WM, dashed border). c) The density of PDGFR-α-positive OPCs was significantly increased in the WM compared to the GM (248.6 ± 23.8 vs. 181.2 ± 7.7, Unpaired, two-tailed Student’s t-test for equal variance, t(6) = 2.69, p = 0.036). d) The percentage PDGFR-α + /EdU+ OPCs is increased in the WM compared to the GM (Unpaired, two-tailed Student’s t-test for equal variance, 51.6 ± 6.6 vs. 14.6 ± 2.5, t(6) = 5.29, p = 0.002). e) Coronal sections from the mid-thoracic spinal cord of healthy Mobp-EGFP mice were taken at P140 and run in parallel with brain sections to confirm the labeling specificity of our oligodendrocyte subpopulation probe-set (Egr2, MOL1, cyan; Klk6, MOL2/3, magenta; Ptgds, MOL5/6, orange). f) Egr2 and Ptgds preferentially label oligodendrocytes in the spinal gray matter, while Klk6 predominantly labels oligodendrocytes in the spinal white matter (Unpaired, two-tailed students t-test for unequal variance). g) Coronal sections from the posterior parietal cortex of Mobp-EGFP mice (−1.7 to −2.3 mm posterior and 1 to 3 mm lateral to bregma) showing the pattern of OL subpopulation labeling at the experimental time points described in (a). *p < 0.05, **p < 0.01, n = 4 mice, 4 sections per mouse. Boxplots represent the median, interquartile range and the minimum and maximum values. For detailed statistics, see Supplementary Table 3.
Extended Data Fig. 8 Modeling oligodendrocyte growth, loss, and regeneration in adult mouse cortex and white matter.
a, b) Cumulative oligodendrocyte population growth (% gain over time) in the healthy brain was modeled using asymptote-restricted exponential mechanistic growth curve-fitting. a) Cumulative OL gain (%) and mechanistic growth fit in the gray matter (left) and the white matter (right) for an example mouse. b) Cumulative OL gain (%) and mechanistic growth fits in the gray matter (left) and the white matter (right) for the healthy group (n = 6 mice). c, d) Cumulative oligodendrocyte population loss (% loss over time) due to cuprizone administration was modeled using three-parameter Gompertz Sigmoid curve-fitting. c) Cumulative OL loss (%) and three-parameter Gompertz curves in the gray matter (left) and the white matter (right) for an example mouse. d) Cumulative OL loss (%) and three-parameter Gompertz curves in the gray matter (left) and the white matter (right) for the cuprizone de/remyelination group (n = 6 mice). e, f) Cumulative oligodendrocyte population regeneration (% cell replacement over time) following cuprizone cessation was modeled using three-parameter Gompertz Sigmoid curve-fitting. e) Cumulative OL replacement (%) and three-parameter Gompertz curves in the gray matter (left) and the white matter (right) for an example mouse. f) Cumulative OL replacement (%) and three-paramter Gompertz curves in the gray matter (left) and the white matter (right) for the cuprizone de/remyelination group (n = 6 mice). Modeled rate and timing metrics in Main Figs. 4–7 were calculated by fitting curves to data from individual mice and then extracting summary data (for example timing of inflection point).
Extended Data Fig. 9 Layer and region-dependent proportions of MOL1, MOL2/3, and MOL5/6 across healthy aging and cuprizone treatment.
Related to Figs. 7,8. a) Raw counts of the total # of segmented Mobp-EGFP OLs (top), MOL1+ OLs (row 2), MOL2/3+ OLs (row 3) and MOL5/6+ OLs (bottom) across cortical and subcortical layers (x-axes) and experimental time points (shaded background colors). Data are from n = 6 mice (Healthy P60), n = 8 mice (Healthy P140), n = 5 mice (Cup. + 4 days) and n = 7 mice (Cup. + 7 weeks), 2 sections per mouse. Bar graphs represent the mean + /- SEM. Data presented in the main figures were expressed either as the percentage of total OLs for each probe (Figs. 7–8), or the change in proportion of each marker from the healthy P140 time point (Figs. 4–6).
Extended Data Fig. 10 Layer-dependent differences in the temporal dynamics of cuprizone-induced loss and regeneration.
a-e) Related to Fig. 7. a) OL population replacement (%) plotted over weekly time bins following cuprizone cessation for each anatomically defined region. Replacement rate is increased from healthy baseline from 2–4 weeks post-cuprizone in L1-3 and CC, and 3–4 weeks post-cuprizone in L4 and L5-6 (Kruskal-Wallis test followed by Steel method for comparison with control, p = 0.034 for L1-3, Weeks 2–4 vs. Healthy; p = 0.034 for L4 Weeks 3–4 vs. Healthy; p = 0.034 for L5-6, Weeks 3–4 vs. Healthy; p = 0.034 for CC Weeks 2–4 vs. Healthy). n = 6 mice (cuprizone), 2 mice were imaged at an extra time point during Week 6. b) First-derivative of the modeled growth curves for healthy baseline and OL replacement (Mechanistic Growth, Gompertz 3P, respectively) showing the response duration of regeneration across regions. c) The regeneration response duration, calculated as the full width at half maximum of the rate curves in (b), is significantly longer in the superficial layers 1–3 compared to the CC (One-way ANOVA followed by Tukey’s HSD, p = 0.048). d) The magnitude of the regeneration response, as calculated by the area under the curve above the healthy baseline rate, is significantly suppressed in L5-6 compared to the CC (One-way ANOVA followed by Tukey’s HSD, p = 0.037). e, f) No significant differences in the duration or magnitude of the cuprizone cell loss response across regions. Data in (a) were calculated based on the raw % change in cell population from baseline. Data in b-f were derived from the modeled and scaled growth curves. n = 6 mice (cuprizone), n = 6 mice (healthy). *p < 0.05, **p < 0.01, n.s. = not significant; for growth curves, cubic splines approximate the measure of center and error bars are 95% confidence intervals; box plots represent the median, interquartile ranges and minimum/maximum values. For detailed statistics, see Supplementary Table 3.
Supplementary information
Supplementary Information
Supplementary Tables 1–3.
Supplementary Video 1
Fly-through of in vivo three-photon microscopy across cortical and subcortical regions in an Mobp–EGFP mouse showing mature oligodendrocytes (green) and THG signal from the vasculature and myelin sheaths (magenta).
Source data
Source Data Fig. 1
Statistical source data.
Source Data Fig. 2
Statistical source data.
Source Data Fig. 3
Statistical source data.
Source Data Fig. 4
Statistical source data.
Source Data Fig. 5
Statistical source data.
Source Data Fig. 6
Statistical source data.
Source Data Fig. 7
Statistical source data.
Source Data Fig. 8
Statistical source data.
Source Data Extended Data Fig.2/Table 2
Statistical source data.
Source Data Extended Data Fig.3/Table 3
Statistical source data.
Source Data Extended Data Fig.5/Table 5
Statistical source data.
Source Data Extended Data Fig.6/Table 6
Statistical source data.
Source Data Extended Data Fig.7/Table 7
Statistical source data.
Source Data Extended Data Fig.8/Table 8
Statistical source data.
Source Data Extended Data Fig.9/Table 9
Statistical source data.
Source Data Extended Data Fig.10/Table 10
Statistical source data.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Thornton, M.A., Futia, G.L., Stockton, M.E. et al. Long-term in vivo three-photon imaging reveals region-specific differences in healthy and regenerative oligodendrogenesis. Nat Neurosci (2024). https://doi.org/10.1038/s41593-024-01613-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41593-024-01613-7